Nobleza, Jocelyn .
HRN: 28-01-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/28/2025
10/31/2025
IV
900 Mg
Every 8 Hours
S/P NSVD Via Non-institutional Delivery; Retained Placenta
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes